{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:16:55Z","timestamp":1794280615397,"version":"4.9.0"},"reference-count":0,"publisher":"BioExcel","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DIC"],"DOI":"10.7573\/dic.2025-4-8","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T06:58:26Z","timestamp":1753340306000},"page":"1-11","source":"Crossref","is-referenced-by-count":1,"title":["Emerging concepts in obesity management: focus on glucagon receptor agonist combinations"],"prefix":"10.7573","volume":"14","author":[{"given":"Sarah L","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10047","published-online":{"date-parts":[[2025,7,24]]},"container-title":["Drugs in Context"],"original-title":[],"link":[{"URL":"https:\/\/www.drugsincontext.com\/wp-content\/uploads\/2025\/07\/dic.2025-4-8.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T06:58:26Z","timestamp":1753340306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.drugsincontext.com\/emerging-concepts-in-obesity-management-focus-on-glucagon-receptor-agonist-combinations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":0,"URL":"https:\/\/doi.org\/10.7573\/dic.2025-4-8","relation":{},"ISSN":["1740-4398"],"issn-type":[{"value":"1740-4398","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]}}}